Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Cohn

Showing results (91-100 of 183) with videos related to

Pageof 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2004
Treatment of relapsed Wilms' tumor with high-dose therapy and autologous hematopoietic stem-cell rescue: the experience at Children's Memorial HospitalAndrew D Campbell, Susan L Cohn, Marleta Reynolds, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2004
Scintigraphic response by 123I-metaiodobenzylguanidine scan correlates with event-free survival in high-risk neuroblastomaHoward M Katzenstein, Susan L Cohn, Richard M Shore, et al.
Journal of the National Cancer Institute|December 18, 2012
Trans-population analysis of genetic mechanisms of ethnic disparities in neuroblastoma survivalEric R Gamazon, Navin Pinto, Anuar Konkashbaev, et al.
Cancer Chemotherapy and Pharmacology|January 2, 2010
Pharmacokinetics of orally administered ABT-751 in children with neuroblastoma and other solid tumorsElizabeth Fox, John M Maris, Susan L Cohn, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
T-cell inflammation is prognostic of survival in patients with high-risk neuroblastoma enriched for an adrenergic signatureMaria E Kaufman, Omar R Vayani, Kelley Moore, et al.
Plos One|September 28, 2011
Secreted protein acidic and rich in cysteine is a matrix scavenger chaperoneAlexandre Chlenski, Lisa J Guerrero, Helen R Salwen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2023
Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk StratificationHannah G Bender, Meredith S Irwin, Michael D Hogarty, et al.
Clinical and Translational Science|February 22, 2026
Hypoxia Promotes an Adrenergic to Mesenchymal Transcriptional Program Transition in NeuroblastomaGepoliano S Chaves, Mohansrinivas Chennakesavalu, Kelley Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group projectWendy B London, Victoria Castel, Tom Monclair, et al.
EJC Paediatric Oncology|January 12, 2024
Persistence of Racial and Ethnic Disparities in Risk and Survival for Patients with Neuroblastoma over Two DecadesMohansrinivas Chennakesavalu, Caileigh Pudela, Mark A Applebaum, et al.
Pageof 19

Showing results (91-100 of 183) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2004
Treatment of relapsed Wilms' tumor with high-dose therapy and autologous hematopoietic stem-cell rescue: the experience at Children's Memorial HospitalAndrew D Campbell, Susan L Cohn, Marleta Reynolds, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2004
Scintigraphic response by 123I-metaiodobenzylguanidine scan correlates with event-free survival in high-risk neuroblastomaHoward M Katzenstein, Susan L Cohn, Richard M Shore, et al.
Journal of the National Cancer Institute|December 18, 2012
Trans-population analysis of genetic mechanisms of ethnic disparities in neuroblastoma survivalEric R Gamazon, Navin Pinto, Anuar Konkashbaev, et al.
Cancer Chemotherapy and Pharmacology|January 2, 2010
Pharmacokinetics of orally administered ABT-751 in children with neuroblastoma and other solid tumorsElizabeth Fox, John M Maris, Susan L Cohn, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
T-cell inflammation is prognostic of survival in patients with high-risk neuroblastoma enriched for an adrenergic signatureMaria E Kaufman, Omar R Vayani, Kelley Moore, et al.
Plos One|September 28, 2011
Secreted protein acidic and rich in cysteine is a matrix scavenger chaperoneAlexandre Chlenski, Lisa J Guerrero, Helen R Salwen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2023
Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk StratificationHannah G Bender, Meredith S Irwin, Michael D Hogarty, et al.
Clinical and Translational Science|February 22, 2026
Hypoxia Promotes an Adrenergic to Mesenchymal Transcriptional Program Transition in NeuroblastomaGepoliano S Chaves, Mohansrinivas Chennakesavalu, Kelley Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group projectWendy B London, Victoria Castel, Tom Monclair, et al.
EJC Paediatric Oncology|January 12, 2024
Persistence of Racial and Ethnic Disparities in Risk and Survival for Patients with Neuroblastoma over Two DecadesMohansrinivas Chennakesavalu, Caileigh Pudela, Mark A Applebaum, et al.
Pageof 19